All Posts

The 2026 MBRRACE-UK report, Saving Lives, Improving Mothers’ Care, offers a disturbing reminder that the danger associated with pregnancy does not end at delivery—or at the traditional six-week postpartum visit. In the United Kingdom, suicide remained the leading cause of maternal death between six weeks and one year after the end of pregnancy. Psychiatric illness also figured prominently during pregnancy and the early postpartum period. Among women who died from direct or in

A global meta-analysis of 418,528 young people found no consistent rise in overall emotional and behavioral symptom burden through 2019. Beneath that apparently stable total, however, the pattern of distress was changing. The sentence every generation repeats “Kids these days” is rarely a neutral observation. It usually carries a diagnosis: children are less resilient, less disciplined, more anxious or simply worse off than those who came before them. The concern is not frivo

Rapid relapse after an antipsychotic is stopped is sometimes interpreted as evidence of pharmacological withdrawal. A new individual-participant-data meta-analysis in The Lancet Psychiatry tested whether that explanation fits the observed clinical pattern. The answer is nuanced. Rapid and delayed relapse trajectories were identified, but rapid relapse was not significantly concentrated among people randomized to discontinue paliperidone. This weighs against a common, distinct

A meta-analysis of 96,676 people linked short-form video use with several forms of psychological distress. Its most important finding was not that every minute is harmful, but that compulsive use appears more closely tied to poor mental health than routine use. A feed with no natural stopping point Short-form video has changed how millions of people encounter entertainment, news, education, health advice, and one another. Each clip is brief; the session often is not. The form

When a Weight-Loss Medicine Meets Alcohol Use Disorder A new randomized trial of oral semaglutide found fewer heavy-drinking days and fewer alcohol-related consequences—but missed its primary craving outcome. The mixed result is precisely why the study deserves attention without hype. An unexpected therapeutic bridge GLP-1 receptor agonists entered public consciousness as treatments for diabetes and obesity. Yet clinicians and patients began reporting something more difficult

What is the “right” plasma clozapine concentration? A new dose-response meta-analysis in Psychiatry Research offers several provocative numbers. But its most important contribution may be its warning against treating those numbers as universal thresholds. Fornaro and colleagues examined the relationships between plasma clozapine and norclozapine concentrations, therapeutic response and adverse outcomes in people with schizophrenia-spectrum disorders. Their findings reinforce

When should an antipsychotic be judged effective—or ineffective? The usual answer is expressed in weeks. But a new study in The Lancet Psychiatry suggests that the more clinically useful question may be: Which symptoms are we waiting to improve? Leucht and colleagues analyzed individual-participant data from six antipsychotic trials involving 2,079 people with acute schizophrenia. Their findings show that the major symptom domains of schizophrenia improve on meaningfully diff

1. Core Framework: "Getting to Zero" (Barry et al., 2016) The primary thesis established by Barry et al. in Current Epidemiology Reports (2016) is that standard TB control measures (prompt case finding and treatment of active disease) are insufficient for elimination. The Latent TB Infection (LTBI) Reservoir: The vast majority of active TB cases in California (>80%) stem from the reactivation of longstanding, untreated latent TB infections rather than recent transmission with

Targeted protein degraders (TPDs), including PROTACs, are emerging as a revolutionary therapeutic strategy for central nervous system (CNS) proteinopathies by leveraging the body's cellular machinery to completely destroy disease-causing misfolded proteins. However, delivering these chemical macromolecules across the blood-brain barrier (BBB) presents a monumental challenge. Standard CNS drugs typically adhere to strict physicochemical parameters, such as low molecular weight

A new and large-scale trend of severe movement disorders has emerged in the United States and Canada, driven by the use of illicit synthetic opioids like fentanyl, often combined with methamphetamines or the veterinary sedative xylazine ("tranq"). Affected individuals frequently present with distinct, marked forward truncal and neck flexion while standing—postural abnormalities colloquially termed the "heroin hunch" or "fentanyl fold". While these abnormal, bent postures are

Understanding "Spice"-Induced Psychosis: A New Clinical Frontier Synthetic cannabinoid receptor agonists (SCRAs), often sold under street names like "Spice" or "K2," have become a global public health concern due to their potent and often unpredictable psychiatric effects. Unlike natural cannabis, these laboratory-engineered molecules bind to brain receptors with much higher affinity, frequently triggering acute psychotic episodes characterized by severe agitation, aggression

Methamphetamine use has emerged as a global public health crisis, second only to cannabis in its prevalence of abuse. While the drug is well-known for its stimulant properties on the central nervous system, its devastating impact on the heart—specifically methamphetamine-associated cardiomyopathy (MAC)—is increasingly reported yet remains under-studied. Clinically, MAC often presents as dilated cardiomyopathy, characterized by enlarged cardiac chambers and a severely reduced

The COVID-19 pandemic triggered an unprecedented surge in alcohol consumption, leading to a significant rise in hospitalizations for alcohol withdrawal syndrome (AWS) . For patients admitted to general hospitals, the sudden interruption of alcohol intake creates an iatrogenic risk for withdrawal, which can range from mild anxiety and tremors to life-threatening conditions like seizures and delirium tremens . Effective management begins with universal screening using validate

While withdrawal symptoms from typical antipsychotics are generally mild and self-limiting, clozapine discontinuation can trigger a severe clinical picture characterized by rapid-onset agitation, delirium, and psychosis. Research into three specific case reports highlights that these symptoms often manifest within days of stopping the medication. Patients may experience a clouding of consciousness, disorientation, and even physical complications like profuse diaphoresis, inco

Delirium remains a significant challenge in intensive care units, affecting nearly 32% of all critically ill patients and surging as high as 91% for those on mechanical ventilation. While haloperidol has traditionally served as the first-line treatment, its association with distressing extrapyramidal side effects and severe sedation has led researchers to explore safer alternatives. A recent randomized controlled trial published in Neurocritical Care investigated whether que

This mixed-method systematic review by Reman et al. (2023) investigates the significant mental health burden associated with female genital mutilation/cutting (FGM/C). By analyzing 14 studies published between 2010 and 2020, the researchers found that women who have undergone FGM/C experience a significantly higher prevalence of psychological disorders compared to those who have not. The primary clinical diagnoses identified include post-traumatic stress disorder (PTSD), depr

Conversion disorder—now termed Functional Neurological Disorder (FND) —has long been viewed through a pessimistic lens, particularly when symptoms persist over time. A major 2025 systematic review and meta-analysis in BMJ Neurology Open challenges that assumption by examining whether symptom chronicity actually limits treatment response . Drawing on 63 studies (27 included in meta-analyses, 885 patients), the authors evaluated outcomes across functional motor disorders,...

Electroconvulsive therapy (ECT) has long been recognized as a powerful tool for treatment-resistant mood disorders, but its impact on long-term survival has remained a subject of clinical debate. A comprehensive new systematic review and meta-analysis published in BMJ Mental Health provides clear evidence that ECT is associated with a 30% reduction in the risk of all-cause mortality among patients with severe unipolar or bipolar depression. This protective effect was found

The Hidden Risks of Dose Escalation A new nationwide register-based study from Finland offers a sobering look at how often new benzodiazepine prescriptions spiral into high-dose usage. Following nearly 50,000 adults who initiated treatment in 2006, researchers tracked their usage patterns over five years and found that dose escalation is alarmingly common. While clinical guidelines universally recommend keeping doses low and durations short, the study revealed that 25.5% of

A significant new meta-analysis published in Acta Psychiatrica Scandinavica has cast a stark light on a major health disparity: the survival gap for cancer patients who have pre-existing severe mental disorders (SMD). Analyzing data across 25 major studies, researchers determined that patients with pre-existing SMD face a 37% higher relative risk of dying from cancer compared to the general population. Crucially, the study found that this risk is most pronounced for individu